SGMO — Sangamo Therapeutics, Inc.

SGMOSangamo Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · sangamo.com

0.2051USD+20.65%Mkt Cap: 80.29M USDP/E: —Last update: 2026-05-26

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap80.29M USD

Enterprise Value56.38M USD

Revenue (TTM)34.56M USD

Gross Profit-78.11M USD

Net Income (TTM)-122.93M USD

Revenue/Share0.1070 USD

Last Price0.2051 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees142

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS8006771062

Valuation

P/E (Trailing)—

P/E (Forward)31.20

PEG—

EV/EBITDA-0.53

EV/Revenue1.63

P/S1.87

P/B-3.39

EPS (TTM)-0.38

EPS (Forward)0.01

52W Range

0.100016% of range0.7700

52W High0.7700 USD

52W Low0.1000 USD

Profitability

Gross Margin-226.04%

Oper. Margin-2215.39%

EBITDA Margin0.00%

Profit Margin-310.81%

ROE861.59%

ROA-205.76%

Growth

Revenue Growth-77.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-97.21M USD

CapEx (TTM)102.00K USD

FCF Margin-135.92%

FCF Yield-58.50%

Net Debt-8.25M USD

Net Debt/EBITDA0.08

Balance Sheet

Debt/Equity-1.88

Current Ratio0.70

Quick Ratio0.64

Book Value/Sh-0.0460 USD

Cash/Share0.0670 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.0 (Buy)

Target (Mean)3.750 USD

Target Range1.000 USD – 10.00 USD

# Analysts4

Ownership

Shares Out.414.29M

Float410.04M

Insiders1.77%

Institutions25.84%

Short Interest

Short Ratio5.5d

Short % Float10.42%

Short % Out.10.35%

Shares Short42.88M

Short (prev mo.)33.48M

Technical

SMA 500.2392 (-14.3%)

SMA 2000.4333 (-52.7%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)13.98M

Avg Vol (10d)4.66M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—